Listen Now
Topics Covered
- Overview of Chronic Lymphocytic Leukemia (CLL), in the Context of COVID-19
- Current Treatment Options, in the Context of COVID-19
- New and Emerging Treatment Approaches
- Clinical Trial Updates
- How Research Increases Your Treatment Options
- The Importance of Communicating with Your Health Care Team about Quality-of-Life Concerns
- The Increasing Role of Telehealth/Telemedicine Appointments
- Questions for Our Panel of Experts
Our Panel of Experts

Adam S. Kittai, MD
Assistant Professor, Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center

Deborah M. Stephens, DO
Assistant Professor, Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, Physician Leader, Hematology Clinical Trials Research Group, Huntsman Cancer Institute, University of Utah

Lindsey E. Roeker, MD
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center

Patricia Koffman
Co-Founder & Communications Director, CLL Society Inc.

Carolyn Messner, DSW, BCD, FAPOS, FAOSW
Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop
Workshop Date
This workshop was originally recorded on March 25, 2021.